Nature of the Event

DCM Shriram Fine Chemicals Limited has issued a Postal Ballot Notice dated September 3, 2026 under Regulation 30 of SEBI (LODR) Regulations, 2015, seeking shareholder approval for five special resolutions through remote e-voting only.

Key Quantitative Figures and Dates

  • Cut-off Date for Voting Eligibility: Friday, September 4, 2026
  • Remote e-Voting Period: From 9:00 a.m. (IST) on Friday, September 11, 2026 to 5:00 p.m. (IST) on Saturday, October 10, 2026
  • Result Declaration Date: Saturday, October 10, 2026
  • Public Deposit Limits:
  • Maximum limit for public deposits: ₹50.09 crore (25% of net worth)
  • Maximum limit for deposits from members: ₹20.03 crore (10% of net worth)
  • Effective Capital: Approximately ₹141.81 crores (as on March 31, 2026)

Parties Involved

  • Registrar & Transfer Agent: KFin Technologies Limited (KFIN)
  • Depositories: NSDL and CDSL
  • Scrutinizer: Mr. Kamaljit, Practicing Company Secretary (CP No. 16847)
  • Stock Exchanges: BSE Limited (Scrip Code: 544703) and National Stock Exchange of India Limited (Symbol: DSFCL)

Resolutions Proposed for Approval

Item No. 1: Appointment of Mr. Nitin Atroley (DIN: 00748485)

  • Position: Non-Executive Independent Director
  • Term: 5 years commencing July 15, 2026
  • Background: Chartered Accountant with 30 years experience in corporate strategy, governance, and talent leadership
  • Previous Role: Chief Strategy, People and Corporate Affairs Officer at KPMG India
  • Remuneration: Sitting fee of ₹50,000 per Board meeting and ₹25,000 per Committee meeting

Item No. 2: Appointment of Mr. Rakesh Malhotra (DIN: 01229765)

  • Position: Non-Executive Independent Director
  • Term: 5 years commencing August 15, 2026
  • Background: Mechanical engineer with 40 years experience in manufacturing and ag-biotechnology
  • Current Directorships: Symbselect Farms Private Limited, Symbiotic Sciences Private Limited, Arm Biotechnologies Private Limited, ARCH Biologics Inc., USA
  • Remuneration: Sitting fee of ₹50,000 per Board meeting and ₹25,000 per Committee meeting

Item No. 3: Appointment of Mr. Rudra Shriram (DIN: 08617576)

  • Position: Director and Managing Director
  • Term: 5 years commencing August 15, 2026
  • Background: B.Sc. in Economics from Purdue University, 12 years experience, fifth-generation member of DCM Shriram legacy
  • Current Position: Deputy Managing Director of DCM Shriram International Limited
  • Remuneration Package:
  • Salary: ₹5.00 lakh per month
  • Housing: Company maintained accommodation or 60% of salary as HRA
  • Medical reimbursement: Actual expenses for self and family
  • Commission: Not exceeding 2% of net profit
  • Other benefits: Company maintained car, communication facilities, club fees (2 clubs)
  • Relationship: Son of Mr. Alok B Shriram, Chairman of the Company

Item No. 4: Appointment of Mr. Anil Kumar Khaitan (DIN: 00759951)

  • Position: Non-Executive Independent Director
  • Term: 5 years commencing September 4, 2026
  • Background: MBA with 48 years experience in multiple industries including jute, paper, pharmaceuticals, copper & steel
  • Current Positions: Managing Director & CEO of Sunil Healthcare Limited, Director of Nada Vibronics Private Limited
  • Remuneration: Sitting fee of ₹50,000 per Board meeting and ₹25,000 per Committee meeting

Item No. 5: Acceptance of Public Deposits

  • Purpose: To invite/accept/renew unsecured deposits from members and public
  • Limit: Total deposits and long-term borrowings shall not exceed limits prescribed under Section 180(1)(c) of Companies Act, 2013
  • Rationale: Continuation of successful practice from demerged company (DCM Shriram Industries Limited) for working capital needs

Voting Arrangements

  • Service Provider: KFin Technologies Limited for remote e-voting facility
  • Eligibility: Members registered as of September 4, 2026 cut-off date
  • Voting Methods: Through NSDL/CDSL portals, depository participants, or KFin website
  • Scrutinizer: Mr. Kamaljit appointed to conduct the postal ballot process

Financial Impact

  • Director appointments involve sitting fees and managerial remuneration as specified
  • Public deposits acceptance will provide working capital financing source
  • No specific quantified financial impact disclosed for the resolutions

Additional Information

  • Notice available on company website: https://dsfcl.com/
  • Material documents available for electronic inspection by members
  • Results will be communicated to BSE and NSE and uploaded on company and KFin websites
  • The company is involved in production and sale of chemicals and contract manufacturing of chemical products